🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.68
-0.16 (-2.74%)
Nov 20, 2026, 5:29 PM CET

AlzeCure Pharma AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
163.52-----
Revenue Growth
------
Gross Profit
163.52-----
Selling, General & Admin
13.6711.8811.4710.610.1711.27
Research & Development
61.9237.4924.827.7146.1866.72
Other Operating Expenses
-4.32-1.4-0.280.040.220.16
Operating Expenses
71.2747.9735.9938.3456.5778.14
Operating Income
92.25-47.97-35.99-38.34-56.57-78.14
Interest Expense
-0.22-0.27-0.35-0.01-0-0
Interest & Investment Income
0.810.490.931.10.210.15
Currency Exchange Gain (Loss)
0.170.080.030.080.130.22
Pretax Income
93.01-47.67-35.38-37.17-56.24-77.78
Income Tax Expense
-0.01-0.02-0.03---
Net Income
93.02-47.65-35.35-37.17-56.24-77.78
Net Income to Common
93.02-47.65-35.35-37.17-56.24-77.78
Net Income Growth
------
Shares Outstanding (Basic)
13010077624838
Shares Outstanding (Diluted)
13010077624838
Shares Change
38.07%30.26%24.26%30.17%26.30%-
EPS (Basic)
0.72-0.47-0.46-0.60-1.18-2.06
EPS (Diluted)
0.72-0.47-0.46-0.60-1.18-2.06
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
99.07-34.59-34.353.06-99.91-70.69
Free Cash Flow Per Share
0.77-0.34-0.450.05-2.10-1.87
Gross Margin
100.00%-----
Operating Margin
56.42%-----
Profit Margin
56.88%-----
Free Cash Flow Margin
60.59%-----
EBITDA
93.45-46.7-35-37.87-56-77.57
D&A For EBITDA
1.21.2710.480.570.58
EBIT
92.25-47.97-35.99-38.34-56.57-78.14